News

Commercial roadmap includes: first joint bGen TES projected expected to launch in 2027, three projects worth $50 million by ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...